MS drug sales drive Questcor profit

July 24 (Reuters) - Questcor Pharmaceuticals Inc posted a 39.5 percent rise in quarterly profit, helped by strong sales of multiple sclerosis drug Acthar.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.